3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
16
INDUSTRY
16
NETWORK
5
NIH
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasm Metastasis
1
Interventions
Radiotherapy, Intensity-Modulated
3
Cisplatin
3
pembrolizumab
2
Metformin
2
Laparoscopy
2
Gemcitabine
2
Capecitabine
2
tremelimumab
1
sintilimab
1
nabiximols
1
lenvatinib
1
enzalutamide
1
durvalumab
1
capivasertib
1
avelumab
1
atezolizumab
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abiraterone
1
Zoledronic Acid
1
Trastuzumab
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Rituximab
1
Rehabilitation
1
Radiotherapy, Conformal
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Radiation
1
Rabeprazole
1
Proton Pump Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
OTHER_GOV
×
tremelimumab
×
Clear all
NCT05000710
2024-12-05
CORAL-Lung
Sheba Medical Center
Phase 2
Active not recruiting
29 enrolled